2017-05-04 08:00:01 CEST
2017-05-04 08:00:01 CEST
BIRTINGARSKYLDAR UPPLÝSNINGAR
Ixonos - Interim report (Q1 and Q3)
Financial statements release for the period January 1 - March 31, 2017
Helsinki, Finland, 2017-05-04 08:00 CEST (GLOBE NEWSWIRE) -- Ixonos Plc
Stock Exchange Release 4 May 2017 at 09:00
Financial statements release for the period January 1 - March 31, 2017
THE TURNOVER GREW AND NET LOSS DECREASED
SUMMARY
The first quarter 2017 in brief (previous-year figures in brackets):
-- Turnover EUR 4.2 (3.9), 8.6 % growth.
-- Earnings before interest, taxes, depreciation and amortization (EBITDA)
EUR -0.7 million,
-16.5 % of turnover (EUR -2.1,-54.2 ).
-- Operating result EUR -0.8 million, -18.8 % of turnover (EUR -2.2, -57.4).
-- Net result EUR -1.2 million, -29.2 % of turnover (EUR -2.8,-72.3 ).
· Earnings per share (undiluted and diluted) EUR 0.00 (EUR -0.01).
· Net cash flow from operating activities EUR -2.0 (EUR -1.8) million.
Future prospects
The operating profit of the company is expected to improve compared to 2016.
CEO’s Review
“During the first quarter of 2017, our business continued to develop into the
same positive direction as in the last quarter of 2016. In January, we
announced the frame agreement that we concluded with the University of Helsinki
concerning digital design services. The agreement is extremely significant for
us, not only because of the new customer relationship, but also because it is a
good example of business model of long-term, close collaboration that we are
aiming for. The turnover increased compared to the corresponding period last
year as well as EBIT, even though it was still negative. This was for example
due to non-recurring expenses related to acquisition and delayed project
starts. We were able to react quickly to these deviations and to correct the
direction towards the end of Q1 back to the targeted level.
In alignment with our strategy, we want to serve our customers with a turnkey
delivery by combining the seamless collection of deep user understanding,
innovative design with uncompromised technological implementation. These kind
of deliveries are related to either improving areas where most development
needs are discovered or ground-breaking solutions based on entirely new service
innovations. Our experience and knowledge in user understanding and LeanLab
strongly support our customers effectively through the life cycle of a product
or service instead of just working as single purpose tools when updating
customers’ strategies.
In the end of the review period we published an important acquisition of
InterQuest Oy, which is very important step in the execution of our strategy.
We have built with determination our knowledge and services related to user-
and user experience research. The acquisition of user research capabilities in
August 2015 was one significant step in this direction. As we see it, different
industries have difficulties in finding the right elements to create meaningful
and successful products and services in the quickly changing and digitalising
world. InterQuest’s LeanLab-service development platform strengthens both
qualitative and quantitative user- and usability research at Ixonos. We can
provide our customers better information about the behaviour of a selected
customer segment and through that support our customers in making successful
decisions. LeanLab is a forerunner in its own area of co-creation tools and it
has tens of satisfied customers both in Finland and abroad.
In our foreign subsidiaries, the key accounts in North America have started to
become stronger. It is very satisfying that the positive trend in winning new
customers has continued. In addition, in the UK our business has developed into
the desired direction and winning new customers over there creates conditions
for a continuation of the same positive direction this year. In Singapore our
presence in strengthened through the acquisition of InterQuest and we are
aiming to grow our business into a new level there.
Our journey as a turnaround company is coming to the point where sustainable
profitability and controlled growth are becoming our main goals. We are working
very decisively towards these goals as a united, global Ixonos-team.” // CEO
Sami Paihonen
SEGMENT REPORTING
Ixonos reports its operations as a single segment.
TURNOVER
Turnover in the fourth quarter was EUR 4.2 (EUR 3.9) million, which represents
8.6% growth compared to the corresponding period. Especially In-Venue focus
area has grown strongly. The comparison period revenue included divested Cloud
business (EUR 0.3 million).
During the review period, no single customer generated a dominating share of
the turnover or exceeded 10 % of the total turnover. The combined turnover of
companies controlled by Savox SA was 21.3% of the Group turnover.
RESULT
The operating result (EBIT) for the first quarter was EUR -0.8 (EUR -2.2)
million and the result before taxes was EUR -1.2 (EUR 2.8) million. The net
result for the first quarter was EUR -1.2 (EUR -2.8) million, earnings per
share were EUR 0.00 (EUR -0.01), and cash flow from operating activities per
share in the first quarter was EUR 0.00 (EUR -0.01).
The main reasons for the result improvement during the review period are the
revenue growth and lightened cost structure.
RETURN ON CAPITAL
The Group's equity was negative EUR -5.4 (EUR 0.2) million and Return on equity
(ROE) was 309.6 (-900.8)%.
Return of investments (ROI) was -54.2 (-34.8)%.
INVESTMENTS
Gross investments during the first quarter totalled EUR 0.0 (0.1) million.
All R&D costs are included in the Group's profit and nothing is capitalised in
the balance sheet.
BALANCE SHEET AND FINANCING
The balance sheet totalled EUR 16.1 (EUR 18.3) million. Shareholders’ equity
was EUR -5.4 (EUR 0.2) million. The equity to total assets ratio was -33.5
(1.3) % The Group’s liquid assets at the end of the review period amounted to
EUR 0.4 (EUR 1.8) million. Non-controlling interest of the equity was EUR 0.0
(EUR 0.2) million.
The change in shareholders’ equity during the review period was due to a
negative result.
At the end of the review period, the balance sheet included EUR 2.8 (EUR 3.1)
million in loans from the financial institutions. This amount covers the
overdrafts in use. The loan agreements from the financial institutions include
covenants regarding equity ratio, which will be considered at the first time 31
December 2017.
In addition to that, the company has loan agreements and convertible bond from
its main owner. The total amount of interest bearing debts 31 March 2017 are
EUR 14.4 million, of which EUR 11.6 million are from related party companies.
New loan agreements with related party companies during the review period are
described in detail in 'related party transactions'.
CASH FLOW
Consolidated cash flow from operating activities during the first quarter was
EUR – 2.0 (EUR -1.8) million, showing a change of -8.5 %.
The Group sells part of its Finnish trade receivables to reduce the turnaround
time of its receivables. During the review period, EUR 1.7 (EUR 1.7) million
trade receivables were sold.
GOODWILL
On 31 March, 2017, the consolidated balance sheet included EUR 11.5 million in
goodwill (EUR 12.0 million).
The following parameters were used in the goodwill impairment testing:
· The review period of 4 years
· WACC discount rate 11 %
· 1 % growth estimate used for terminal value calculation
Ixonos conducted an impairment test on 31 March 2017, confirming that there is
no need for any other impairment. The present value of future cash flows
exceeded the carrying value of assets by EUR 20.1 million.
The present value of the cash flow calculation of EUR 31.6 million is lower
than the sum of the Company's financial liabilities (i.e. EUR 14.4 million) and
the market price of the shares (i.e. EUR 46.0 million) as of 31 March 2017.
PERSONNEL
The average number of employees during the first quarter was 168 (201), and at
the end of the period, there were 166 (199) employees. At the end of the review
period, the Group had 133 (161) employees stationed in Finnish companies, while
Group companies in other countries employed 33 (38). During the review period,
the number of employees decreased by three.
SHARES AND SHARE CAPITAL
Share turnover and price
During the first quarter, the highest price of the Ixonos’ share was EUR 0.16
(0.07) and the lowest price was EUR 0.10 (0.06). The closing price on 31 March
2017 was EUR 0.13 (0.06). The weighted average price was EUR 0.14 (0.06). The
number of shares traded during the review period was 17.664.167 (3.255.707),
which corresponds to 4.99 % (0.9) of the total number of shares at the end of
the review period. The market value of the share capital was EUR 45.963.437
(21.213.894) at closing on 31 March 2017.
Share capital
At the beginning of the review period, the company’s registered share capital
was EUR 585.394.16 and the number of shares was 353.564.898. At the end of the
review period, the registered share capital was EUR 585.394.16 and the number
of shares was 353.564.898.
Option plans 2011, 2014 and 2016
Ixonos Plc has three Option plans: 2011, 2014 and 2016 plans, The maximum
total number of new company shares to be subscribed for based on these stock
options shall be 42.018.526. The option plans are described on company’s
website www.ixonos.com.
Shareholders
On 31 March 2017, Ixonos had 3.706 shareholders (3.055). Private persons owned
12.72% (12.6), institutions owned 86.74% (86.8), and foreigners owned 0.54%
(0.5). Nominee-registered ownership was 1.41% (1.8) of all shares.
Tremoko Oy Ab, a related party, owns 82.2% of the Company’s shares. Options
held by Tremoko can increase their ownership to 82.3%.
Related-party transactions
On 3 February 2017, the company has secured a loan agreement in order to
strengthen its working capital with Tremoko Oy Ab. The loan agreement enables,
if necessary, additional financing for a maximum of 1.0 million Euros.
On 3 March 2017, the company has accepted the binding offer of its main owner
Tremoko Oy Ab of a financial arrangement based on borrowed capital of at most
EUR 2.0 million (“Financial Arrangement”). The Financial Arrangement is
combined with the additional financial arrangement of EUR 1.0 million
implemented earlier and announced on 3 February 2017. Thus, the Financial
Arrangement executed now enables, if necessary, Ixonos Plc to obtain EUR 1.0
million more than earlier in additional financing. The additional financing
under the Financial Arrangement falls due 31 January 2019 at the latest.
Annual General Meeting on 29 March 2017
The Company held its Annual General Meeting on 29 March 2017. The minutes of
the Annual General Meeting and decisions are presented on the Company’s
internet page, www.ixonos.com.
Paul Ehrnrooth, Bo-Erik Ekström, Pekka Eloholma, Samu Konttinen, Päivi Marttila
and Pekka Pylkäs were re-elected as members of the Board of Directors and Peter
Eriksson was elected as a new member.
At its constitutive meeting following the Annual General Meeting, the Board of
Directors elected Paul Ehrnrooth as Chairman of the Board and Päivi Marttila as
Deputy Chairman.
Accordingly, the members of the audit committee of the Board were selected in
the meeting. Päivi Marttila was elected as Chairman of the Audit Committee and
Bo-Erik Ekström and Pekka Eloholma as its members.
Stock Exchange releases during the period are available on company’s website
www.ixonos.com/investors/releases
EVENTS AFTER THE REPORTING PERIOD
13.4.2017 Ixonos Plc has concluded an agreement by which the Finnish company
Interquest Oy becomes part of the Ixonos group. With the sale, Ixonos further
strengthens its global position as a leading end-to-end digital transformation
service provider and enables Ixonos clients to enjoy broader, deeper and faster
service globally. As a result of the acquisition, Ixonos will also become the
biggest User Insight company in the Nordics, specialized in modern user
experience research.
In the transaction, all Interquest shares apart from shares owned by the
company itself were transferred to the ownership of Ixonos. As consideration,
Ixonos issued a total of 12 012 990 new Ixonos shares (“Consideration Shares”)
in a directed share issue (“Share Issue”) to be subscribed for by the current
owners of Interquest. The Share Issue shall be carried out in derogation from
the pre-emptive subscription right of the shareholders by the decision of
Ixonos’ Board of Directors on the authorisation of the Annual General Meeting
held on 7 April 2016. The Consideration Shares issued in the Share Issue were
issued in order to develop the group’s business and finance the corporate
transaction, so there is a weighty financial reason for the Share Issue and the
deviation from the pre-emptive right of the shareholders within the meaning of
the Finnish Limited Liability Companies Act. The subscription price of the
Consideration Shares (“Subscription Price”) in the Share Issue was EUR 0,115
per Consideration Share. The Subscription Price was defined as the mean price
weighted with the trading amounts of the Ixonos share of the period 28
September 2016 – 28 March 2017. The Owners have subscribed the Consideration
Shares in total and the Board of Directors of Ixonos has accepted the share
subscription made in the Share Issue on 13 April 2017 when the acquisition of
Interquest was concluded.
The Consideration Shares will represent 3.3 per cent of Ixonos shares and votes
after the Share Issue. The Consideration Shares will entitle to full dividends
possibly distributed by Ixonos and to other distribution of assets as well as
carry other shareholder rights in the company starting from when the
Consideration Shares have been entered in the Trade Register and the
shareholders’ register of the company. A certain part of the Consideration
Shares of Ville Österlund, continuing to work for the group, are subject to a
lock-up period of six (6) months to two (2) years starting from the issue of
such shares.
In connection with closing of the acquisition of shares in Interquest Oy on 13
April 2017 Ixonos Plc issued a total of 12,012,990 new shares. The shares have
been registered with the Finnish Trade Register on 19 April 2017 and were
admitted to public trade on the Nasdaq Helsinki stock exchange approximately on
20 April 2017 in the same class of shares as the company’s old shares. Ixonos
now has a total of 365,577,888 shares and votes.
The acquisition price EUR 1.432.709 will preliminary be recognised in customer
agreements and IPR rights.
26 April 2017, Ixonos Plc signed an agreement whereby it acquired the
Digitalist business of the Finnish Rome Advisors Oy together with the
associated intellectual property rights and brands . By combining Ixonos’
know-how of research, design and technology with the Digitalist business’
unique way of bringing together experts, know-how and companies, the
combination of the business operations and the resulting Digitalist Network
will enable a new kind of co-operation and create tomorrow’s experiences
already today. The corporate transaction supports the realisation of the
company’s strategy, and the reborn company will lead the way in implementing
digitalisation-related know-how in different fields of business.
Rome Advisors Oy is a Finnish company, which provides management consulting
services and specialises in creating digital strategies. The company helps
corporations to understand the opportunities of growth, change and
digitalisation, and teaches them to use the network in business and to build
new ways to operate in the digital age. Ville Tolvanen, CEO of of Rome
Advisors, has also founded the Digitalist Network and acts as its General
Secretary.
With the transaction, Rome Advisors Oy’s #DIGITALIST business and related
assets and rights have transferred to Ixonos. Ixonos has paid the Purchase
Price by a directed share issue (“Share Issue 1”) in which it directed
altogether 2 677 074 new Ixonos shares (“Consideration Shares”) to be
subscribed for by Rome Advisors Oy. In connection with the Transaction, Ixonos
also directed altogether 2 294 635 new Ixonos shares (“Share”) to be subscribed
for by Rome Advisors Oy in a directed share issue which is to be paid in cash
(“Share Issue 2”) and is separate from the Transaction.
Share Issue 1 and Share Issue 2 (jointly “Share Issues”) were carried out in
derogation from the pre-emptive subscription right of the shareholders by the
decision of Ixonos’ Board of Directors on the authorisation of the Annual
General Meeting held on 29 March 2017. The Consideration Shares issued in Share
Issue 1 are issued in order to develop the group’s business and finance the
corporate transaction, so the company has a weighty financial reason for Share
Issue 1 and for the deviation from the pre-emptive right of the shareholders
within the meaning of the Finnish Limited Liability Companies Act. The funds
derived from Share Issue 2 will be used to maintain and improve the solvency of
the group, so the company has weighty financial reasons for Share Issue 2 and
for deviating from the pre-emptive right of the shareholders within the meaning
of the Finnish Limited Liability Companies Act.
The subscription price of the Shares in the Share Issues is approximately EUR
0.131 per Consideration Share and Share. The Subscription Price has been
determined as the mean price weighted with the trading amounts of the Ixonos
share of the period 25 January 2017 – 25 April 2017. The subscription of the
Consideration Shares and Shares has taken place at the signing of the
transaction and the Board of Directors of Ixonos has accepted the share
subscriptions.
The Consideration Shares and Shares will represent altogether 1.3 per cent of
Ixonos shares and votes after the Share Issues. The Consideration Shares and
Shares will entitle to full dividends possibly distributed by Ixonos and to
other distribution of assets as well as carry other shareholder rights in the
company starting from when the Consideration Shares and Shares have been
entered in the Trade Register and the shareholders’ register of the company.
The Consideration Shares are subject to a lock up period of one (1) – two (2)
years starting from the issue of such shares.
27 April 2017 Ixonos Plc gave notice to the Shareholders to an Extraordinary
General Meeting to be held 19 May 2017 at 5 pm at the company’s head office.
The Board of Directors proposes that section “§ 1 Company name and domicile” of
Ixonos Plc’s Articles of Association be amended to be the following: The
company’s name is Digitalist Group Oyj, Digitalist Group Abp in Swedish and
Digitalist Group Plc in English. The company’s registered office is in
Helsinki.
The Notice of Ixonos Plc’s extraordinary general meeting is available on
company’s website
www.ixonos.com/investors/releases.
RISK MANAGEMENT AND NEAR-FUTURE UNCERTAINTY FACTORS
Ixonos Plc’s risk management aims to ensure undisturbed continuity and
development of the Company’s operations, support attainment of the commercial
targets set by the Company and promote increasing Company value. Details on
risk management organisation and process, as well as on recognised risks, are
presented on the Company’s website at www.ixonos.com.
Despite efficiency actions taken, Ixonos Plc results have been negative during
recent years, which has directly impacted Ixonos’ sufficiency of working
capital. The risk related to sufficient working capital is managed by
maintaining readiness for various financing methods.
Changes in key customer accounts may have adverse effects on Ixonos’
operations, earning power and financial position. Should a major customer
switch its purchases from the Company to its competitors or make forceful
changes to its own operating model, Ixonos would have limited ability to
acquire, in the short term, new customer volume to compensate for such changes.
The Group’s turnover consists primarily of relatively short-term customer
contracts. Forecasting the starting dates and scope is from time to time is
challenging; yet at the same time, the cost structure is fairly rigid. This may
result in unexpected fluctuations in turnover and profitability.
Part of the Company’s business operations is based on fixed-price project
deliveries. Fixed-price projects may include risks related to their duration
and content. These risks are being managed by means of contract management as
well as project management.
Some part of the Group’s turnover is invoiced in foreign currency. Risks
related to currency fluctuation are managed through different means.
The Group has a subsidiary in Great Britain. The Brexit influence on the
operations of the subsidiary has been evaluated and the influence is estimated
to be insignificant.
The Company’s balance sheet includes a significant amount of goodwill, which
may still be impaired should internal or external factors reduce the profit
expectations of the Company’s cash flow. Goodwill is tested each quarter and,
if necessary, at other times.
The company’s financial agreements have covenants attached to them. A covenant
breach may increase the company’s financial expenses or lead to a call for
swift partial or full repayment of non-equity loans. The main risks related to
covenant breaches are associated with EBITDA fluctuation due to the market
situation and with a potential need to increase the company’s working capital
through non-equity funding. The company manages these risks by negotiating with
financiers and by maintaining readiness for various financing methods.
LONG-TERM GOALS AND STRATEGY
In the long term, Ixonos aims to achieve an operating result of at least 10 per
cent. To reach its long-term goals, Ixonos focuses its strategy on deepening
the company’s service and solution business and combining user- and user
experience research, design and technology. The company aims to grow with new
accounts within different industries by repeating Ixonos unique way to offer
business advantage through digitalisation and mobility.
NEXT REPORTS
The financial statement for the period 1 April – 30 June, 2017 will be
published on Wednesday, 23 August, 2017.
IXONOS PLC
Board of Directors
For more information, please contact:
Ixonos Plc
- Sami Paihonen, President and CEO, tel. +358 50 502 1111,
sami.paihonen@ixonos.com
- Kristiina Simola, CFO, tel. +358 40 756 3132, kristiina.simola@ixonos.com
Distribution:
NASDAQ OMX Helsinki
Main media
THE IXONOS GROUP
SUMMARY OF INTERIM REPORT AND NOTES TO THE INTERIM REPORT 1 January – 31 March,
2017
CONSOLIDATED INCOME STATEMENT, EUR 1.000
1.1.-31.3.17 1.1.-31.3.16 Change % 1.1.-31.12.1
6
--------------------------------------------------------------------------------
Turnover 4 236 3 901 8.6 15 256
--------------------------------------------------------------------------------
Operating expenses -5 034 -6 141 -18.0 -22 993
--------------------------------------------------------------------------------
OPERATING RESULT -798 -2 240 64.4 -7 736
--------------------------------------------------------------------------------
Financial income and -440 -578 24.0 -1 811
expenses
--------------------------------------------------------------------------------
Result before tax -1 237 -2 819 56.1 -9 547
--------------------------------------------------------------------------------
Income tax 0 0 0 -2
--------------------------------------------------------------------------------
RESULT FOR THE PERIOD -1 237 -2 819 56.1 -9 550
--------------------------------------------------------------------------------
Attributable to:
--------------------------------------------------------------------------------
Equity holders of the parent -1 237 -2 816 100.0 -9 550
--------------------------------------------------------------------------------
Non-controlling interests 0 -2 100.0 0
--------------------------------------------------------------------------------
Earnings per share
--------------------------------------------------------------------------------
Undiluted, EUR 0.00 -0.01 56.1 -0.03
--------------------------------------------------------------------------------
Diluted, EUR 0.00 -0.01 65.8 -0.02
--------------------------------------------------------------------------------
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME, EUR 1.000
1.1.-31.3.1 1.1.-31.3.1 Change % 1.1.-31.12.
7 6 16
--------------------------------------------------------------------------------
Result for the period -1 237 -2 819 56.1 -9 550
--------------------------------------------------------------------------------
Other comprehensive income
--------------------------------------------------------------------------------
Change in translation 34 374 -91.0 538
difference
--------------------------------------------------------------------------------
COMPREHENSIVE RESULT FOR THE -1 204 -2 444 50.8 -9 012
PERIOD
--------------------------------------------------------------------------------
CONSOLIDATED STATEMENT OF FINANCIAL POSITION, EUR 1.000
ASSETS 31.3.2017 31.3.2016 31.12.2016
--------------------------------------------------------------------------------
NON-CURRENT ASSETS
--------------------------------------------------------------------------------
Goodwill 11 543 12 043 11 543
--------------------------------------------------------------------------------
Other intangible assets 249 470 323
--------------------------------------------------------------------------------
Property, plant and equipment 324 365 340
--------------------------------------------------------------------------------
Deferred tax assets 0 0 0
--------------------------------------------------------------------------------
Available-for-sale investments 8 22 8
--------------------------------------------------------------------------------
Trade and other receivables 78 0 156
--------------------------------------------------------------------------------
TOTAL NON-CURRENT ASSETS 12 201 12 900 12 370
--------------------------------------------------------------------------------
CURRENT ASSETS
--------------------------------------------------------------------------------
Trade and other receivables 3 519 3 639 3 304
--------------------------------------------------------------------------------
Cash and cash equivalents 448 1 809 422
--------------------------------------------------------------------------------
TOTAL CURRENT ASSETS 3 968 5 448 3 726
--------------------------------------------------------------------------------
TOTAL ASSETS 16 091 18 348 16 095
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
EQUITY AND LIABILITIES 31.3.2017 31.3.2016 31.12.2016
--------------------------------------------------------------------------------
SHAREHOLDERS’ EQUITY
--------------------------------------------------------------------------------
Share capital 585 585 585
--------------------------------------------------------------------------------
Share premium reserve 219 219 219
--------------------------------------------------------------------------------
Invested non-restricted equity fund 47 191 46 969 47 191
--------------------------------------------------------------------------------
Retained earnings -52 149 -44 936 -42 645
--------------------------------------------------------------------------------
Result for the period -1 237 -2 816 -9 550
--------------------------------------------------------------------------------
Equity attributable to equity holders of the -5 390 22 -4 199
parent
--------------------------------------------------------------------------------
Non-controlling interests 0 219 0
--------------------------------------------------------------------------------
TOTAL SHAREHOLDERS’ EQUITY -5 390 241 -4 199
--------------------------------------------------------------------------------
LIABILITIES
--------------------------------------------------------------------------------
Non-current liabilities 12 153 6 295 10 215
--------------------------------------------------------------------------------
Current liabilities 9 238 11 713 10 078
--------------------------------------------------------------------------------
TOTAL LIABILITIES 21 481 18 107 20 294
--------------------------------------------------------------------------------
TOTAL EQUITY AND LIABILITIES 16 091 18 348 16 095
--------------------------------------------------------------------------------
STATEMENT OF CHANGES IN CONSOLIDATED SHAREHOLDERS’ EQUITY, EUR 1.000
A: Share capital
B: Share premium reserve
C: Share Issue
D: Invested non-restricted equity fund
E: Translation difference
F: Retained earnings
G: Total equity attributable to equity holders of the parent
H: Non-controlling interests
I: Total equity
A B C D E F G H I
--------------------------------------------------------------------------------
Shareholders’ equity at 585 219 0 46 994 -259 -45 054 2 487 221 2 708
January 1, 2015
--------------------------------------------------------------------------------
Other changes
--------------------------------------------------------------------------------
Result for the period -2 816 -2 816 -3 -2 819
--------------------------------------------------------------------------------
Other comprehensive -1 -1
income:
--------------------------------------------------------------------------------
Change in translation 374 -374 374
difference
--------------------------------------------------------------------------------
Transactions with
shareholders:
--------------------------------------------------------------------------------
Share issue
--------------------------------------------------------------------------------
Expenses for equity -25 -25 -25
procurement
--------------------------------------------------------------------------------
Share-based 2 2 2
remuneration
--------------------------------------------------------------------------------
Shareholders’ equity at 585 219 0 46 969 116 -47 869 22 219 241
March 31, 2016
--------------------------------------------------------------------------------
Shareholders’ equity at 585 219 0 47 190 280 -52 475 -4 421 -4 199
January 1, 2017
--------------------------------------------------------------------------------
Other changes
--------------------------------------------------------------------------------
Result for the period -1 237 -1 237 -1 237
--------------------------------------------------------------------------------
Other comprehensive
income
--------------------------------------------------------------------------------
Change in translation 34 34 34
difference
--------------------------------------------------------------------------------
Transactions with
shareholders:
--------------------------------------------------------------------------------
Equity part of the
convertible bond
--------------------------------------------------------------------------------
Expenses for equity
procurement
--------------------------------------------------------------------------------
Share-based 12 12 12
remuneration
--------------------------------------------------------------------------------
Shareholders’ equity at 585 219 0 47 190 314 -53 700 -5 613 5 390
March 31, 2017 -
--------------------------------------------------------------------------------
CONSOLIDATED CASH FLOW STATEMENT, EUR 1,000
31.3.2017 31.3.2016 31.12.2016
--------------------------------------------------------------------------------
Cash flow from operating activities
--------------------------------------------------------------------------------
Result for the period -1,237 -2,819 -9,550
--------------------------------------------------------------------------------
Adjustments to cash flow from operating
activities
--------------------------------------------------------------------------------
Income tax 0 0 1
--------------------------------------------------------------------------------
Other income and expenses with no payment 0 0 500
relation
--------------------------------------------------------------------------------
Depreciation and impairment 101 127 505
--------------------------------------------------------------------------------
Financial income and expenses 222 578 1 511
--------------------------------------------------------------------------------
Other adjustments 46 -336 -997
--------------------------------------------------------------------------------
Cash flow from operating activities before -868 -2,449 -8,029
change in working capital
--------------------------------------------------------------------------------
Change in working capital -977 755 2,841
--------------------------------------------------------------------------------
Interest received 0 1 2
--------------------------------------------------------------------------------
Interest paid -20 -70 -280
--------------------------------------------------------------------------------
Tax paid 0 0 -1
--------------------------------------------------------------------------------
Net cash flow from operating activities -1,864 -1,763 -5,467
--------------------------------------------------------------------------------
Cash flow from asset sale agreement 0 0 550
--------------------------------------------------------------------------------
Investments in tangible and intangible assets -11 -44 -364
--------------------------------------------------------------------------------
Net cash flow from sale of tangible assets 0 0 47
--------------------------------------------------------------------------------
Net cash flow from investing activities -11 -44 233
--------------------------------------------------------------------------------
Net cash flow before financing -1,876 -1,807 -5,234
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Cash flow from financing activities
--------------------------------------------------------------------------------
Increase in long-term borrowings 2,000 24 4,394
--------------------------------------------------------------------------------
Increase in short-term borrowings 1 1,918 47
--------------------------------------------------------------------------------
Repayment of short-term borrowings -63 -63 -253
--------------------------------------------------------------------------------
Expenses for equity procurement 0 -25 -24
--------------------------------------------------------------------------------
Financial leasing payments -35 -139 -457
--------------------------------------------------------------------------------
Net cash flow from financing activities 1,902 1,715 3,755
--------------------------------------------------------------------------------
Change in cash and cash equivalents 26 -92 -1,479
--------------------------------------------------------------------------------
Liquid assets at the beginning of the period 422 1,901 1,901
--------------------------------------------------------------------------------
Liquid assets at the end of the period 448 1,809 422
--------------------------------------------------------------------------------
Accounting principles
This interim report has been prepared in accordance with IAS 34 (Interim
Financial Reporting) and the accounting policies for the annual financial
statement of December 31, 2014. The IFRS amendments and interpretations that
entered into force on January 1, 2016 have not affected the consolidated
financial statements.
For IFRS 15 implementation the Group has assessed all customer agreements whre
the project delivery has taked place during the review period. Based on these
agreemtnts there will not be significant effects on revenue when IFRS 15 is
implemented.
Preparing interim reports in accordance with IFRS requires Ixonos’ management
to make estimates and assumptions that affect the amounts of assets and
liabilities on the balance sheet date as well as the amounts of income and
expenses for the financial period. In addition, judgement must be used in
applying the accounting policies. As the estimates and assumptions are based on
views prevailing at the time of releasing the interim report, they involve
risks and uncertainty factors. Actual results may differ from estimates and
assumptions.
The figures in the income statement and balance sheet are consolidated. The
consolidated balance sheet includes all group companies. The original annual
report is in Finnish. The annual report in English is a translation of the
original report.
As the figures in the report have been rounded, sums of individual figures may
differ from the sums presented. The annual report is unaudited.
Going Concern
This annual report has been prepared according to the going concern principle
taking into account the realized financial arrangements during the financial
year 2017 and financial estimations made up for the year 2017. The estimations
take into consideration probable or foreseeable changes in future expectations
in revenues as well as in costs. On the balance sheet day, the company
estimated that its existing working capital is sufficient to cover the
company’s funding needs over the next 12 months.
Loan agreements include semi-annual covenants regarding equity ratio, which
will be considered at the first time on 31 December 2017. The total amount of
loan agreements that include loan covenants are 2.5 million euros.
Goodwill impairment
Ixonos made an impairment testing for the goodwill value on the balance sheet
on 31 March, 2017. The goodwill is attributed to the one cash generating unit
(CGU) starting from November 1, 2013.
The impairment test showed a surplus of EUR 20.1 million based on discounted
cash flow valuation compared to tested amount and no impairment was recognized.
The carrying amount of goodwill is EUR 11.5 million. The present value of the
cash flows calculated, EUR 31.6 million is lower than the sum of the company's
financial liabilities (EUR 14.4 million) and the market price of the shares
(EUR 46 million) on 31 March 2016.
The impairment test of the company is based on operative company value. The
forecasting period used in impairment testing at 31 March 2016 was Q2 2017 to
Q1 2021.
In the forecast, the year 2017 is a year of relatively small growth. For the
years 2018-2021 the company expects to reach stronger growth, on average of 16
per cent, as digitalization will impact an ever growing part of the business
community. The forecasted EBIT level is assumed to increase to on average of 10
per cent. Even though the company’s long-term target level for EBIT is 10 per
cent the uncertainty of forecasts has been taken into consideration and
therefore the average, normalized EBIT level has been used in the calculation.
The impairment test is done by comparing the carrying value of assets to
present value of future cash flow taking into consideration forecasted cash
flows during the forecast period, discount factor and growth rate used in
calculating terminal value. The discount factor used is 11 per cent p.a. and
growth rate used in calculating terminal value is 1 per cent p.a. When
calculating the terminal value, the weighted average EBIT %age level for the
period was used.
The impairment test is most sensitive besides to the cash flow forecast itself
and the assumptions behind it, to the growth rate used when calculating the
terminal value and to the discount factor. If the growth rate -31 per cent had
been used instead of 1 per cent, the tested value would have been equal to the
discounted cash flow. If the discount factor had been 24.6 per cent instead of
11 per cent, the tested value would have been equal to the discounted cash
flow. If the EBIT %age used had been 0.4 per cent instead of 10 per cent, the
tested value would have been equal to the discounted cash flow.
Loan covenants
The Company has a total amount of bank loans on 31 March 2017 EUR 2.8 million.
The amount of loans that include covenants are 2.4 (5.2) million euros 31 March
2017.
The loan agreements include covenants regarding equity ratio, which will be
considered at the first time on 31 December, 2017. Should the company not be
within the limits of a covenant, the creditor is entitled to call in the loans
to which that covenant applies. The covenant levels are reviewed semi-annually
on a rolling twelve-month basis after 31 December 2017. The equity ratio must
be minimum 30 per cent.
On 31 March 2017 the company's equity ratio was -33.5 per cent (1.3 per cent)
Instalment scheme for loans under covenants:
Period Amount of bank loan
instalment EUR 1.000
01.01 - 31.12.2017 253
01.01. - 31.12.2018 2 190
CONSOLIDATED INCOME STATEMENT, QUARTERLY, EUR 1.000
Q1/2017 Q4/2016 Q3/2016 Q2/2016 Q1/2016
1.1.-31. 1.10.-31.1 1.7.-30. 1.4.-30. 1.1.-31.
3.17 2.16 9.16 6.16 3.16
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Turnover 4 236 4 489 3 037 3 830 3 901
--------------------------------------------------------------------------------
Operating expenses -5 034 -5 572 -5 050 -6 229 -6 141
--------------------------------------------------------------------------------
OPERATING PROFIT BEFORE -798 -1 083 -2 014 -2 400 -2 240
GOODWILL IMPAIRMENT
--------------------------------------------------------------------------------
Financial income and -440 -231 -495 -506 -578
expenses
--------------------------------------------------------------------------------
Result before tax -1 237 -1 341 -2 510 -2 905 -2 818
--------------------------------------------------------------------------------
Income tax 0 -1 0 -1 0
--------------------------------------------------------------------------------
RESULT FOR THE PERIOD -1 237 -1 315 -2 510 -2 906 -2 819
--------------------------------------------------------------------------------
CHANGES IN FIXED ASSETS, EUR 1.000
Goodwill Intangible Property, plant Availab Total
assets and equipment le-
for-sal
e
investm
ents
--------------------------------------------------------------------------------
Carrying amount at 12 043 548 372 23 12 986
January 1, 2015
--------------------------------------------------------------------------------
Additions 0 0 44 0 44
--------------------------------------------------------------------------------
Changes in exchange 0 0 -3 -1 -4
rates
--------------------------------------------------------------------------------
Disposals and 0 0 0 0 0
transfers
--------------------------------------------------------------------------------
Impairment 0 0 0 0 0
--------------------------------------------------------------------------------
Depreciation for the 0 -78 -49 0 -127
period
--------------------------------------------------------------------------------
Carrying amount at 12 043 470 365 22 12 900
March 31, 2016
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Carrying amount at 11 543 323 340 8 12 214
January 1, 2016
--------------------------------------------------------------------------------
Additions 0 0 11 0 11
--------------------------------------------------------------------------------
Changes in exchange 0 0 0 0 0
rates
--------------------------------------------------------------------------------
Disposals and 0 0 0 0 0
transfers
--------------------------------------------------------------------------------
Impairment 0 0 0 0 0
--------------------------------------------------------------------------------
Depreciation for the 0 -74 -27 0 -101
period
--------------------------------------------------------------------------------
Carrying amount at 11 543 249 324 8 12 124
March 31, 2017
--------------------------------------------------------------------------------
FINANCIAL RATIOS
1.1.-31.3.2017 1.1.-31.3.2016 1.1-31.12.2016
--------------------------------------------------------------------------------
Earnings per share, diluted, EUR 0,00 -0,01 - 0,03
--------------------------------------------------------------------------------
Earnings per share, EUR 0,00 -0,01 -0 03
--------------------------------------------------------------------------------
Equity per share, EUR -0,02 0,00 -0,01
--------------------------------------------------------------------------------
Operating cash flow per share, 0,00 -0,05 -0,01
diluted, EUR
--------------------------------------------------------------------------------
Operating cash flow per share, -0,01 -0,005 -0,01
EUR
--------------------------------------------------------------------------------
Return on investment, per cent -54,2 -34,8 -70,1
--------------------------------------------------------------------------------
Return on equity, per cent 309,6 -900,8 1,5
--------------------------------------------------------------------------------
Operating result ∕ turnover, per -18,8 -57,4 -50,7
cent
--------------------------------------------------------------------------------
Net gearing from total equity, -259,7 4 424,2 -288,3
per cent
--------------------------------------------------------------------------------
Equity ratio, per cent -33,5 1,3 -26,1
--------------------------------------------------------------------------------
Equity ratio, per cent, -33,5 0,1 -26,1
excluding non-controlling
interest
--------------------------------------------------------------------------------
EBITDA, 1.000 EUR -697 -2 113 -7 231
--------------------------------------------------------------------------------
OTHER INFORMATION
1.1.-31.3.2017 1.1.- 31.3.2016 1.1.-31.12.2016
--------------------------------------------------------------------------------
PERSONNEL
--------------------------------------------------------------------------------
Employees, average 168 201 188
--------------------------------------------------------------------------------
Employees, at the end of the 166 199 174
period
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
COMMITMENTS, EUR 1.000
--------------------------------------------------------------------------------
Collateral for own commitments 23 500 23 500 23 500
--------------------------------------------------------------------------------
Corporate mortgages 0 0 0
--------------------------------------------------------------------------------
Financial bonds
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Leasing and other rental
commitments
--------------------------------------------------------------------------------
Falling due within 1 year 959 1 136 831
--------------------------------------------------------------------------------
Falling due within 1-5 years 1 443 231 1 307
--------------------------------------------------------------------------------
Falling due after 5 years 0 0 0
--------------------------------------------------------------------------------
Total 2 402 1 367 2 043
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Nominal value of interest rate
swap agreement
--------------------------------------------------------------------------------
Falling due within 1 year 253 253 253
--------------------------------------------------------------------------------
Falling due within 1-5 years 190 443 253
--------------------------------------------------------------------------------
Falling due after 5 years 0 0 0
--------------------------------------------------------------------------------
Total 443 696 506
--------------------------------------------------------------------------------
Fair value -5 -13 -7
--------------------------------------------------------------------------------
CALCULATION OF KEY FIGURES
EBITDA = Earnings before Interest, Taxes and Depreciation and Amortization
Diluted earnings per share = result for the period ∕ number of shares, adjusted
for issues and dilution, average
Earnings per share = result for the period ∕ number of shares, adjusted for
issues, average
Shareholders’ equity per share = shareholders’ equity ∕ number of shares,
undiluted, on the closing date
Cash flow from operating activities, per share, diluted = net cash flow from
operating activities ∕ number of shares, adjusted for issues and dilution,
average
Return on investment = (result before taxes + interest expenses + other
financial expenses) ∕ (balance sheet total - non-interest-bearing liabilities,
average) × 100
Return on equity = net result ∕ shareholders’ equity, average × 100
Net gearing from total equity= (interest-bearing liabilities - liquid assets) /
shareholders’ equity × 100
© 2024 Nasdaq, Inc. All Rights Reserved |